These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38018421)

  • 1. ELABELA protects against diabetic kidney disease by activating high glucose-inhibited renal tubular autophagy.
    Zheng X; Yin L; Song J; Chen J; Gu W; Shi M; Zhang H
    J Biomed Res; 2023 Nov; 37(6):460-469. PubMed ID: 38018421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
    Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L
    Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.
    Chen Z; Wang Z; Hu Y; Lin H; Yin L; Kong J; Zhang Y; Hu B; Li T; Zheng X; Yang Q; Ye S; Wang S; Zhou Q; Zheng C
    Inflammation; 2023 Dec; 46(6):2343-2358. PubMed ID: 37540330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
    Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease.
    Dong J; Liu M; Bian Y; Zhang W; Yuan C; Wang D; Zhou Z; Li Y; Shi Y
    Diabetes Metab Syndr Obes; 2024; 17():75-92. PubMed ID: 38196512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elabela, a Novel Peptide, Exerts Neuroprotective Effects Against Ischemic Stroke Through the APJ/miR-124-3p/CTDSP1/AKT Pathway.
    Zhang KL; Li SM; Hou JY; Hong YH; Chen XX; Zhou CQ; Wu H; Zheng GH; Zeng CT; Wu HD; Fu JY; Wang T
    Cell Mol Neurobiol; 2023 Aug; 43(6):2989-3003. PubMed ID: 37106272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats.
    Schreiber CA; Holditch SJ; Generous A; Ikeda Y
    Curr Gene Ther; 2017; 16(5):349-360. PubMed ID: 27903222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Elabela-APJ axis: a promising therapeutic target for heart failure.
    Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
    Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes.
    Zhang H; Gong D; Ni L; Shi L; Xu W; Shi M; Chen J; Ai Y; Zhang X
    Cell Physiol Biochem; 2018; 48(3):1347-1354. PubMed ID: 30048993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.
    Yang P; Read C; Kuc RE; Buonincontri G; Southwood M; Torella R; Upton PD; Crosby A; Sawiak SJ; Carpenter TA; Glen RC; Morrell NW; Maguire JJ; Davenport AP
    Circulation; 2017 Mar; 135(12):1160-1173. PubMed ID: 28137936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
    Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
    J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing.
    Hong Y; Li J; Zhong Y; Yang S; Pei L; Huang Z; Chen X; Wu H; Zheng G; Zeng C; Wu H; Wang T
    iScience; 2023 Sep; 26(9):107601. PubMed ID: 37664606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelinergic system in the kidney: implications for diabetic kidney disease.
    Müller T; Kalea AZ; Marquez A; Hsieh I; Haque S; Ye M; Wysocki J; Bader M; Batlle D
    Physiol Rep; 2018 Dec; 6(23):e13939. PubMed ID: 30548130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean red ginseng attenuates hyperglycemia-induced renal inflammation and fibrosis via accelerated autophagy and protects against diabetic kidney disease.
    Karunasagara S; Hong GL; Park SR; Lee NH; Jung DY; Kim TW; Jung JY
    J Ethnopharmacol; 2020 May; 254():112693. PubMed ID: 32112899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition.
    Wu Z; Li D; Tian D; Liu X; Wu Z
    PLoS One; 2022; 17(12):e0279010. PubMed ID: 36516169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways.
    Fu J; Chen X; Liu X; Xu D; Yang H; Zeng C; Long H; Zhou C; Wu H; Zheng G; Wu H; Wang W; Wang T
    Stem Cell Res Ther; 2020 Dec; 11(1):541. PubMed ID: 33317626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
    Hu Y; Tang W; Liu W; Hu Z; Pan C
    Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
    Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
    Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.